Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Zhejiang Hengkang Deferasirox

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Deferasirox

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 401Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Torrent`s Generics Deferasirox Receives Approval in US
    Torrent`s Generics Deferasirox Receives Approval in US

    05 Nov 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209426

    FDA
    05 Nov 2024
    Share Share
    Mylan's Generic Deferasirox Receives Approval in the U.S.
    Mylan's Generic Deferasirox Receives Approval in the U.S.

    17 May 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206585

    FDA
    17 May 2024
    Share Share
    Mylan's Generic Deferasirox Receives Approval in the U.S.
    Mylan's Generic Deferasirox Receives Approval in the U.S.

    03 May 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213146

    FDA
    03 May 2024
    Share Share
    Enforcement Report - Week of November 15, 2023
    Enforcement Report - Week of November 15, 2023

    15 Nov 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-15-2023-17266.pdf

    FDA
    15 Nov 2023
    Share Share
    Teva's Generic Deferasirox Receives Approval in the U.S.
    Teva's Generic Deferasirox Receives Approval in the U.S.

    23 Sep 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207124

    FDA
    23 Sep 2022
    Share Share
    Annora's Generic Deferasirox Receives Approval in the U.S.
    Annora's Generic Deferasirox Receives Approval in the U.S.

    22 Sep 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216229

    FDA
    22 Sep 2022
    Share Share